Xiao-Hong Chen Selected Research

4-(2'-pyridyldithio)benzyldiazoacetate (PPDA)

1/2022

Enhanced function of NR2C/2D-containing NMDA receptor in the nucleus accumbens contributes to peripheral nerve injury-induced neuropathic pain and depression in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiao-Hong Chen Research Topics

Disease

10	Neoplasms (Cancer) 02/2022 - 04/2011
5	Carcinoma (Carcinomatosis) 01/2021 - 09/2013
4	Cardiomegaly (Heart Hypertrophy) 01/2020 - 01/2016
3	Rhinosinusitis 01/2022 - 05/2019
3	Fibrosis (Cirrhosis) 01/2019 - 02/2009
3	Squamous Cell Carcinoma of Head and Neck 01/2018 - 06/2008
3	Asthma (Bronchial Asthma) 05/2014 - 06/2007
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2022 - 01/2021
2	Inflammation (Inflammations) 01/2022 - 05/2015
2	Nasal Polyps (Nasal Polyp) 01/2022 - 01/2020
2	Lung Neoplasms (Lung Cancer) 06/2021 - 01/2021
2	Atrophy 01/2018 - 03/2013
2	Bronchiolitis 02/2017 - 11/2013
2	Alzheimer Disease (Alzheimer's Disease) 05/2015 - 03/2013
2	Pain (Aches) 03/2014 - 08/2002
2	Laryngeal Neoplasms (Laryngeal Cancer) 09/2013 - 07/2004
2	Infections 09/2013 - 09/2012
2	Liver Cirrhosis (Hepatic Cirrhosis) 09/2012 - 02/2009
2	Wounds and Injuries (Trauma) 01/2010 - 07/2009
1	Hematologic Neoplasms (Hematological Malignancy) 02/2022
1	Neuralgia (Stump Neuralgia) 01/2022
1	Mental Disorders (Mental Disorder) 01/2022
1	Hyperalgesia 01/2022
1	Glucocorticoid Receptor Deficiency 01/2022
1	Substance-Related Disorders (Drug Abuse) 01/2022
1	Atherosclerosis 01/2022
1	Peripheral Nerve Injuries 01/2022
1	Chronic Pain 01/2022
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 03/2021
1	Extensively Drug-Resistant Tuberculosis 03/2021
1	Prostatitis 02/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2021
1	Occupational Stress 01/2021
1	Alveolar Rhabdomyosarcoma 11/2020
1	Hypertrophy 01/2020
1	Acidosis 11/2018
1	Respiratory Tract Infections (Respiratory Tract Infection) 11/2018
1	Hypoglycemia (Reactive Hypoglycemia) 11/2018
1	Heart Arrest (Cardiac Arrest) 11/2018
1	Reye Syndrome (Reye's Syndrome) 11/2018
1	Fever (Fevers) 11/2018

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2012
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2007
4	EnzymesIBA 05/2014 - 01/2007
3	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2020 - 01/2017
3	triptolideIBA 01/2020 - 01/2016
2	CytokinesIBA 02/2022 - 01/2022
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2022 - 02/2017
2	NLR ProteinsIBA 01/2022 - 01/2019
2	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2020
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 06/2021 - 01/2017
2	Pharmaceutical PreparationsIBA 03/2021 - 06/2015
2	Interleukin-6 (Interleukin 6)IBA 02/2021 - 01/2007
2	Small Interfering RNA (siRNA)IBA 01/2021 - 09/2013
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 12/2013
2	Indicators and Reagents (Reagents)IBA 12/2020 - 12/2013
2	Angiotensin IIIBA 01/2020 - 01/2019
2	Budesonide (Pulmicort)FDA LinkGeneric 05/2019 - 06/2007
2	salicylhydroxamic acid (SHAM)IBA 08/2017 - 03/2014
2	Messenger RNA (mRNA)IBA 09/2013 - 10/2009
2	ImmunosorbentsIBA 05/2013 - 01/2007
2	Fetal Proteins (Fetoprotein)IBA 09/2012 - 04/2011
2	Hydroxyproline (4 Hydroxyproline)IBA 02/2009 - 06/2007
1	Chimeric Antigen ReceptorsIBA 02/2022
1	pinitolIBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022
1	4-(2'-pyridyldithio)benzyldiazoacetate (PPDA)IBA 01/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Caspase 1 (ICE Protease)IBA 01/2022
1	Biological ProductsIBA 06/2021
1	bedaquiline (R207910)IBA 03/2021
1	Capsules (Microcapsules)IBA 02/2021
1	Tamsulosin (Flomax)FDA LinkGeneric 02/2021
1	Therapeutic UsesIBA 02/2021
1	TESIBA 01/2021
1	AntigensIBA 01/2021
1	Trace Elements (Biometals)IBA 01/2021
1	CalreticulinIBA 01/2021
1	CollagenIBA 01/2019
1	Protein Kinases (Protein Kinase)IBA 01/2019
1	Immunologic Factors (Immunomodulators)IBA 01/2019
1	JNK Mitogen-Activated Protein KinasesIBA 01/2019
1	InflammasomesIBA 01/2019
1	Myeloid Differentiation Factor 88IBA 01/2019
1	Carnitine (L-Carnitine)FDA LinkGeneric 11/2018
1	nimesulide (Aulin)IBA 11/2018
1	ethylmalonic acid (ethylmalonate)IBA 11/2018

Therapy/Procedure

4	Therapeutics 02/2022 - 09/2013
4	Drug Therapy (Chemotherapy) 11/2020 - 04/2008
3	Aftercare (After-Treatment) 02/2021 - 09/2007
2	Immunotherapy 02/2022 - 01/2021
2	Ligation 08/2017 - 10/2009
2	Analgesia 03/2014 - 08/2002
1	Electroacupuncture 02/2021
1	Nursing Care 01/2021
1	Induction Chemotherapy 12/2020
1	Brachytherapy 11/2020
1	Oral Administration 11/2018